SCHEMBL30768097

SCHEMBL30768097

Cc1cc2cnc(NC3CCN(S(=O)(=O)c4cnn(C)c4)CC3)nc2c(Cl)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 20/20 0.52
▸ CCNE1 P24864 14/20 0.52
▸ CDK1 P06493 5/20 0.52
▸ CCNB1 P14635 5/20 0.52
▸ CCNB2 O95067 3/20 0.52
▸ CCNE2 O96020 3/20 0.52
▸ CDK5 Q00535 3/20 0.52
▸ CDK5R1 Q15078 3/20 0.52
▸ CCNB3 Q8WWL7 3/20 0.52
▸ CCND1 P24385 5/20 0.51
▸ CDK6 Q00534 5/20 0.51
▸ CCNT1 O60563 2/20 0.51
▸ CDK4 P11802 2/20 0.51
▸ CCND3 P30281 2/20 0.51
▸ CDK9 P50750 2/20 0.51
▸ CDK7 P50613 1/20 0.51
▸ CCNH P51946 1/20 0.51
▸ MNAT1 P51948 1/20 0.51
▸ CCNA2 P20248 6/20 0.44
▸ CCNK O75909 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27035003 1.00 CDK2 (0.52) CDK2CCNE1CDK1CCNB1CCNB2
SCHEMBL30726194 0.84 CCNE1 (0.57) CDK2CCNE1CDK1CCNB1CCNB2
SCHEMBL27033634 0.84 CCNE1 (0.57) CDK2CCNE1CDK1CCNB1CCNB2
SCHEMBL27034820 0.83 CCNE1 (0.49) CDK2CCNE1CDK1CCNB1CCNB2
SCHEMBL30768109 0.83 CCNE1 (0.49) CDK2CCNE1CDK1CCNB1CCNB2
SCHEMBL30761953 0.80 CDK2 (0.50) CDK2CCNE1CDK1CCNB1CCNB2
SCHEMBL27035016 0.80 CDK2 (0.50) CDK2CCNE1CDK1CCNB1CCNB2
SCHEMBL22977319 0.80 CDK2 (0.67) CDK2CCNE1CDK1CCNB1CCNB2
SCHEMBL29631714 0.80 CDK2 (0.53) CDK2CCNE1CDK1CCNB1CCNB2
SCHEMBL24477981 0.80 CDK2 (0.53) CDK2CCNE1CDK1CCNB1CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4558502-A1 AZA-QUINAZOLINE COMPOUNDS AND METHODS OF USE Iambic Therapeutics, Inc. (US) 2025-05-28 — — EP disclosed
WO-2024020419-A1 AZA-QUINAZOLINE COMPOUNDS AND METHODS OF USE IAMBIC THERAPEUTICS, INC. (US) 2024-01-25 — — WO disclosed
Send feedback